FDA Grants Clearance for Joimax’s Vaporflex and Legato Electrosurgical Probes
Joimax has received 510(k) clearance from the FDA to market its Vaporflex and Legato electrosurgical probes with radio-wave technology for open and endoscopic spine surgery.
The Joimax electrosurgical devices are comprised of a series of components to facilitate the delivery of electrical energy from an RF generator to the patient tissue for use in cutting and/or coagulation of tissue.
All Vaporflex and Legato probes use radio frequency which is generated by high oscillating electrical current received from a commercially available RF generator. — Cynthia Jessup